BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26814330)

  • 1. Retraction Note: Adenosine triphosphate treatment for supraventricular tachycardia in infants.
    Eur J Pediatr; 2015 Nov; 174(11):1559. PubMed ID: 26814330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenosine triphosphate and supraventricular tachycardia].
    Pella J
    Vnitr Lek; 1994 Nov; 40(11):702-6. PubMed ID: 7810092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of retractions related to faked peer reviews: an overview.
    Qi X; Deng H; Guo X
    Postgrad Med J; 2017 Aug; 93(1102):499-503. PubMed ID: 27663911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants].
    Haas NA; Pufahl C; König SA; Gessler P; Teufel M
    Dtsch Med Wochenschr; 1994 Oct; 119(40):1351-6. PubMed ID: 7924940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine use in pregnant women with supraventricular tachycardia.
    Hagley MT; Cole PL
    Ann Pharmacother; 1994 Nov; 28(11):1241-2. PubMed ID: 7849336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of supraventricular tachycardia in children].
    Norgård G; Greve G; Hals J
    Tidsskr Nor Laegeforen; 1996 Oct; 116(26):3124-9. PubMed ID: 8999574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants.
    Paret G; Steinmetz D; Kuint J; Hegesh J; Frand M; Barzilay Z
    Am J Perinatol; 1996 Aug; 13(6):343-6. PubMed ID: 8865979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experience with adenosine triphosphate in supraventricular arrhythmia].
    Sochman J
    Vnitr Lek; 1992 May; 38(5):458-65. PubMed ID: 1509715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction Note to: Preference for immediate reinforcement over delayed reinforcement: relation between delay discounting and health behavior.
    J Behav Med; 2015 Oct; 38(5):835. PubMed ID: 26613108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial.
    Shaker H; Jahanian F; Fathi M; Zare M
    Ther Adv Cardiovasc Dis; 2015 Feb; 9(1):4-9. PubMed ID: 25297337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD; Kirchhoffer JB; Modesto TA
    Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction notice to "Long-Term Trends (1986-2003)in the Use of Coronary Reperfusion Strategies in Patients Hospitalized With Acute Myocardial Infarction in Central Massachusetts" [Int. J Cardiol. 131 (2008) (83-89)].
    Goldberg RJ; Spencer FA; Okolo J; Lessard D; Yarzebski J; Gore JM
    Int J Cardiol; 2017 May; 235():207. PubMed ID: 28342504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Childhood treatment of paroxysmal supraventricular tachycardia using i.v. adenosine].
    Pfammatter JP; Stocker FP; Weber JW; Fasnacht M; Friedli B; Günthard J; Payot M
    Schweiz Med Wochenschr; 1993 Oct; 123(40):1870-4. PubMed ID: 8211040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
    Schläpfer J; Fromer M; Kappenberger L
    Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETRACTED: Relationship between the angiotensinogen A1166C gene polymorphism and the risk of diabetes mellitus developing into diabetic nephropathy.
    Yang CH; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP45. PubMed ID: 28102727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Association of the ACE I/D gene polymorphism with sepsis susceptibility and sepsis progression.
    Yang CH; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP51. PubMed ID: 28102726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Association between the ACE I/D gene polymorphism and T2DN susceptibility: The risk of T2DM developing into T2DN in the Asian population.
    Zhong W; Jiang Z; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP35. PubMed ID: 28102725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTED: Association of the angiotensinogen M235T gene polymorphism with risk of diabetes mellitus developing into diabetic nephropathy.
    Tang W; Zhou TB; Jiang Z
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP27-NP34. PubMed ID: 28102723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RETRACTED: Relationship between the ACE I/D gene polymorphism and T1DN susceptibility/risk of T1DM developing into T1DN in the Caucasian population.
    Zhou TB; Guo XF; Jiang Z; Li HY
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP18. PubMed ID: 28102722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review.
    Dadi G; Fink D; Weiser G
    Cardiol Young; 2017 Jul; 27(5):981-984. PubMed ID: 27989257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.